Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (...

FDA Drug Recall #D-0421-2015 — Class II — February 18, 2015

Recall Summary

Recall Number D-0421-2015
Classification Class II — Moderate risk
Date Initiated February 18, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mylan Institutional LLC
Location Rockford, IL
Product Type Drugs
Quantity 11,030 cartons (55,150 vials)

Product Description

Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103

Reason for Recall

Lack of Assurance of Sterility; due to leaking vials

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Lot 7602281, Exp 4/16; Lot 7602283, Exp 4/16

Other Recalls from Mylan Institutional LLC

Recall # Classification Product Date
D-0601-2021 Class III Thiamine HCl Injection, USP 200 mg/2 mL (100mg/... May 3, 2021
D-1575-2020 Class I Amiodarone Hydrochloride Injection, USP, 450 mg... Aug 17, 2020
D-1576-2020 Class I Tranexamic Acid Injection, USP, 1000 mg/10 mL (... Aug 17, 2020
D-1484-2020 Class I Daptomycin for Injection, 500 mg/vial, Single-D... Jul 7, 2020
D-1271-2020 Class II Aloprim (allopurinol sodium) for Injection, 500... May 5, 2020

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.